Condition: Mucopolysaccharidosis IH/S · Mucopolysaccharidosis IS · Sponsor: Immusoft of CA, Inc.
A first-in-human study using ISP-001 in patients with Mucopolysaccharidosis Type I Hurler-Scheie and Scheie.
This description comes directly from the study's public registry record.
Jake Wesley, PharmD, MS · jake.wesley@immusoft.com
Always discuss trial participation with your own doctor first.
| UCSF Benioff Children's Hospital Oakland | Oakland, California, United States | Recruiting |
| University of Minnesota | Minneapolis, Minnesota, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05682144